11/07/2013 18:45:00

U.K. Recalls Drugs Made in India

LONDON--In another sign of possible manufacturing problems in India's pharmaceutical industry, the U.K.'s medicines regulator said it was recalling 16 drugs made by Wockhardt Ltd. (532300.BY) after finding "manufacturing deficiencies" at one of the company's factories in India.

The Medicines and Healthcare products Regulatory Agency, or MHRA, called it a "precautionary recall," as there is no evidence that the medicines are defective. The agency said it is recalling the drugs from pharmacies and wholesalers but isn't asking patients to return their Wockhardt medicines.

"There is no evidence of a patient safety risk. ...however, the MHRA has to act in the interest of public health as poor manufacturing standards cannot be allowed to continue," the agency said.

The recalled drugs, manufactured in the central Indian city of Waluj, include treatments for infections, hypertension, diabetes, epilepsy and other diseases. The MHRA said the plant suffered from "poor cleaning practices" and defective ventilation systems. The agency inspection also found evidence of "forged documents relating to staff training records."

In an emailed statement, Wockhardt confirmed the news and said the recall would result in a one-time charge of 1.5 million pounds ($2.25 million) this year. Exports from the Waluj plant constitute less than 5% of the company's total U.K. sales and less than 2% of overall sales, it added.

It was the second recent setback for the company and its Waluj factory. In May, the U.S. Food and Drug Administration imposed an import ban on products from the factory after it failed an FDA safety inspection. The FDA didn't elaborate on the problems it found.

In a conference call at the time, Wockhardt Chairman Habil Khorakiwala said the company was implementing "corrective measures to be in compliance with the FDA guidelines." He said the U.S. import ban could cost the company $100 million in revenue this fiscal year. Wockhardt generated total revenue of 25.6 billion rupees ($460.6 million) in the year ended March 31, 2012.

Also in May, India's Ranbaxy Laboratories Ltd. (500359.BY) agreed to pay $500 million in civil and criminal fines for exporting adulterated drugs to the U.S.

In a phone interview Thursday, D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry body, said the group has written to the FDA asking it to conduct workshops with Indian companies to correct erroneous practices.

"Companies need to better understand FDA processes, and there needs to be a correction in their organizational culture, right from drug discovery to development and production," Mr. Shah said.

Write to Jeanne Whalen at jeanne.whalen@wsj.com and Anirban Chowdhury at anirban.chowdhury@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 11, 2013 13:45 ET (17:45 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
27 Mar
OMXC20
  Det kan være næsten lige så vanedannende som narkotika og cigaretter at sidde dag efter dag og føl..
27
23 Mar
I:DAX
@marc55.   Lad mig give dig et velment råd.   Jeg er ikke en gammel sur mand (hverken gammel eller s..
19
26 Mar
 
Aktieugebrevet skriver:   Zealand Pharma kan stå foran stor værdiskabelse Zealand Pharma aktien har ..
17
22 Mar
OMXC25
Det var så vigtigt vi skulle stemme. Jeg er glad for det blev et NEJ.   EU sagde vi ikke ville få en..
17
28 Mar
BAVA
Regnearket er bygget op, på den måde, at det udregner Gak prisen løbende. I GAK prisen, er der altså..
16
23 Mar
VWS
Dong Energy og Vestas får meldinger om off shore industrien, hvor de store olieselskaber øjnene muli..
14
28 Mar
 
Nej. Det er derimod latterligt, at Uber skal være ulovligt i dette i forvejen over regulerede lortel..
13
28 Mar
 
Det var da på tide. De skulle aldrig have åbnet. Man kan da ikke starte et firma, der åbenlyst laver..
13
22 Mar
GEN
Genmab kommer minimum i kurs 2000 over tid - og hvad der sker i mellemtiden rager mig personligt en ..
13
24 Mar
DANSKE
Hr. Borgen og kongsmart sad i kantinen og så gårdsdagens nyheder i tv, da Der Tonede et indslag fre..
12

Form 8.3 - Bovis Homes Group Plc

28/03/2017 14:49:02
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Unicredit SpA (b) Owner or controller of interests an..

Alliance Trust PLC : Net Asset Value(s)

28/03/2017 13:55:21
ALLIANCE TRUST PLC                                    At the close of business on Monday 27 March 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 714.6p -       including income, 720.4p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income..

HSBC Bank Plc : Form 8.5 (EPT/RI) - Redrow PLC

28/03/2017 10:41:26
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offe..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Under Armour, Inc. To Contact The Firm
2
Ericsson presents focused business strategy
3
RigNet deploys its first deep water 4G LTE system in the Gulf of Mexico and announces dramatic capacity increases to its state-of-the-art licensed 4G wireless network
4
Ericsson simplifies organization and names Executive Team
5
PICO Holdings, Inc. to Webcast Annual Meeting of Shareholders on May 4th, 2017

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
29 March 2017 06:18:00
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170324.2 - EUROWEB4 - 2017-03-29 07:18:00 - 2017-03-29 06:18:00 - 1000 - Website: OKAY